3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Doxorubicin
14
Specimen Handling
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
10
Biopsy
10
Cyclophosphamide
9
X-Rays
7
Radiotherapy
7
Ifosfamide
7
Phantoms, Imaging
6
Nivolumab
6
Gemcitabine
6
tazemetostat
5
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
palbociclib
4
fludarabine
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
larotrectinib
3
cabozantinib
3
atezolizumab
3
Trabectedin
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Ipilimumab
3
Carboplatin
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
trastuzumab biosimilar HLX02
×
90 days
×
Clear all
No trials found.